The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from Cancer and Leukemia Group B 9480.
- Citation:
- Clin Cancer Res vol 11 (5) 1815-20
- Year:
- 2005
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA 31946
- Corr. Author:
- Authors:
- Daniel J George Susan Halabi Timothy F Shepard Ben Sanford Nicholas J Vogelzang Eric J Small Philip W Kantoff
- Networks:
- Study
- INT-0159
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adenocarcinoma, Aged, Antineoplastic Agents, Hormonal, Cohort Studies, Drug Resistance, Neoplasm, Humans, Interleukin-6, Male, Middle Aged, Multivariate Analysis, Neoplasm Metastasis, Prognosis, Prostate-Specific Antigen, Prostatic Neoplasms, Survival Analysis